Quantitative Renal Uptake Using TC99m DMSA in Hypertensive &/or Diabetic Patients.

Status

UNKNOWN

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03123237

Enrollment

Registered

2017-04-21

Start date

2016-07-31

Completion date

2017-12-31

Last updated

2017-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Hypertension

Brief summary

the investigators explore the possible role of DMSA to detect renal affection in diabetic &/or hypertensive patients by detecting difference in counts using Tc 99m DMSA in control & diabetic &/or hypertensive patients.

Interventions

DIAGNOSTIC_TESTDMSA scan

We explore the possible role of DMSA to detect renal affection in diabetic &/or hypertensive patients by detecting difference in counts using Tc 99m DMSA in control & diabetic &/or hypertensive patients.

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* • Patients with diabetes (type2), weather controlled or not. * Patients with essential hypertension. * Patients with diabetes & hypertension. * Within normal renal function (urea & creatinine). * Control cases may be normal individuals (apparently healthy) like donors for renal transplant.

Exclusion criteria

* • Patients with abnormal renal function. * Patients with diseases known to affect kidney function rather diabetes & hypertension e.g. SLE, heart failure or liver cell failure.

Design outcomes

Primary

Measure	Time frame	Description
Renal Counts	2-4 hours	Quantitative Tc99m DMSA renal scan using SPECT technique will be used to measure renal function.

Countries

Egypt

Contacts

Primary ContactHeba Askar, MsC

hebaaskar@aun.edu.eg+201003040898

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026